Monday, October 13, 2014

Diabetic Macular Edema Treatment Injections

Diabetic Macular Edema is a common cause of vision loss in diabetics suffering from the effects of diabetic retinopathy. We are fortunate to have a number of treatment options including injections of Vascular Endothelial Growth Inhibitor (VEGF) drugs such as Lucentis® & Eyelea® that are helpful to treat and reverse the effects of Diabetic Macular Edema.

Researchers reporting in the British Journal of Ophthalmology shared helpful information about the importance of the VEGF inhibitor injection frequency and duration in the treatment of diabetic macular edema. The study confirmed that patients need to be patient as their ophthalmologists plan and schedule their examinations, testing and visits as sometime the best results can only be achieved multiple injections over some period of time. In general good long term results are achieved by about 4 months of injection treatment, but 20% of patients with persistent Diabetic Macular Edema at 12 months achieved a dry macula with considerable restoration of vision with sustained treatment through 24 months suggesting that persistent Diabetic Macular Edema at 4-12 months should not be used as a stopping criterion for treatment.

If you or someone you know has a question about diabetic retinopathy including diabetic macular edema with Lucentis® or Eyelea® injections please feel free to call Northwest Indiana Eye & Laser Center at 219-464-8223, or visit Northwest Indiana Eye & Laser Center or facebook.com/nwindianaeyeandlaser to schedule an appointment.

Northwest Indiana Eye & Laser Center offices are located at 522 Marquette Street, Valparaiso, Indiana 46383 and 1001 South Edgewood Drive, Knox, Indiana 46354.